Douglas Cines, MD
Hematology · Philadelphia, PANPI 1548203342
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,304 of the $44,181 with a category attached, or 75.4%. 8 manufacturers reported payments, led by Dova Pharmaceuticals at 32.5% of the total. Reporting peaked in 2022 at $11,538 and has fallen 72.9% since, to $3,125 in 2025.
Across 31 payments — averaging $1425.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dova Pharmaceuticals$14K
- Argenx US, Inc.$8K
- Novartis$7K
- Rigel Pharmaceuticals, Inc.$4K
- Sobi, Inc$4K
- Recordati_rare_diseases_inc.$3K
- plus $4K from 2 others
What the payments were for
- Consulting fees$33,30475%
- Speaking & faculty fees$7,75018%
- Travel & lodging$2,4566%
- Food & beverage$6702%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dova Pharmaceuticals | 7 | $14,359 |
| Argenx US, Inc. | 10 | $7,838 |
| Novartis | 4 | $7,126 |
| Rigel Pharmaceuticals, Inc. | 6 | $4,184 |
| Sobi, Inc | 1 | $3,700 |
| Recordati_rare_diseases_inc. | 1 | $3,125 |
| Amgen | 1 | $2,049 |
| CSL Behring | 1 | $1,800 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,181 in reported general payments places this provider in the 85th percentile of 64 hematology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Philadelphia
- Selina LugerPhiladelphia$122K
- Scott DessainPhiladelphia$79K
- Dan VoglPhiladelphia$79K
- Edward StadtmauerPhiladelphia$72K
- Sanaa RizkPhiladelphia$55K
- Adam CukerPhiladelphia$38K
- Ralph VassalloPhiladelphia$32K
- Elizabeth HexnerPhiladelphia$23K
- Scott PeslakPhiladelphia$21K
- Samir BallasPhiladelphia$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.